- Home
- ALVO vs FBK Comparison
ALVO vs FBK Comparison
Compare ALVO & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- FBK
- Stock Information
- Founded
- ALVO 2013
- FBK 1906
- Country
- ALVO Luxembourg
- FBK United States
- Employees
- ALVO N/A
- FBK N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- ALVO Health Care
- FBK Finance
- Exchange
- ALVO Nasdaq
- FBK Nasdaq
- Market Cap
- ALVO 2.5B
- FBK 2.1B
- IPO Year
- ALVO N/A
- FBK 2016
- Fundamental
- Price
- ALVO $8.30
- FBK $58.35
- Analyst Decision
- ALVO Strong Buy
- FBK Buy
- Analyst Count
- ALVO 1
- FBK 5
- Target Price
- ALVO $14.00
- FBK $59.00
- AVG Volume (30 Days)
- ALVO 369.2K
- FBK 455.0K
- Earning Date
- ALVO 11-12-2025
- FBK 10-14-2025
- Dividend Yield
- ALVO N/A
- FBK 1.31%
- EPS Growth
- ALVO N/A
- FBK N/A
- EPS
- ALVO 0.22
- FBK 1.94
- Revenue
- ALVO $562,478,000.00
- FBK $410,807,000.00
- Revenue This Year
- ALVO $36.61
- FBK $34.11
- Revenue Next Year
- ALVO $42.30
- FBK $22.63
- P/E Ratio
- ALVO $38.16
- FBK $29.96
- Revenue Growth
- ALVO 82.19
- FBK N/A
- 52 Week Low
- ALVO $7.35
- FBK $38.83
- 52 Week High
- ALVO $13.70
- FBK $60.52
- Technical
- Relative Strength Index (RSI)
- ALVO 49.12
- FBK 68.88
- Support Level
- ALVO $8.03
- FBK $54.90
- Resistance Level
- ALVO $8.96
- FBK $60.52
- Average True Range (ATR)
- ALVO 0.34
- FBK 1.11
- MACD
- ALVO 0.04
- FBK 0.22
- Stochastic Oscillator
- ALVO 32.75
- FBK 69.79
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.